TY - CHAP M1 - Book, Section TI - Dermatological Pharmacology A1 - Sewell, Matthew J. A1 - Morrell, Dean S. A2 - Brunton, Laurence L. A2 - Knollmann, Björn C. Y1 - 2023 N1 - T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition AB - AbbreviationsAPC: antigen-presenting cellAUC: area under the curveBCC: basal cell carcinomacAMP: 3′,5′-cyclic adenosine monophosphate (cyclic AMP)CBC: complete blood cell countCCR4: C-C chemokine receptor 4CTCL: cutaneous T-cell lymphomaCTLA4: cytotoxic T lymphocyte–associated protein 4DEET: diethyltoluamide (N,N-diethyl-m-toluamide)DHT: dihydrotestosteroneECP: extracorporeal photopheresisEn1: engrailed-1EMA: European Medicines AgencyFDA: U.S. Food and Drug Administration5FU: 5-fluorouracilGI: gastrointestinalGM-CSF: granulocyte-macrophage colony-stimulating factorG6PD: glucose-6-phosphate dehydrogenaseGRASE: generally recognized as safe and effectiveHPV: human papillomavirusHSV: herpes simplex virusIFN: interferonIL: interleukinIVIG: intravenous immunoglobulinJAK: Janus kinaseMRGPR: Mas-related G protein-coupled receptorMRSA: methicillin-resistant Staphylococcus aureusmTOR: mammalian (or mechanistic) target of rapamycinNSAID: nonsteroidal anti-inflammatory drugODC: ornithine decarboxylaseOTC: over the counterPABA:p-aminobenzoic acidPD-1: programmed death-1PDE: cyclic nucleotide phosphodiesterasePDT: photodynamic therapyPUVA: psoralen and UVARAR: retinoic acid receptorREMS: risk evaluation and mitigation strategyRXR: retinoid X receptorS1PR1: sphingosine-1-phosphate receptor 1SPF: sun protection factorSSD: silver sulfadiazineSSTI: skin and soft-tissue infectionSTAT: signal transducer and activator of transcriptionTNFα: tumor necrosis factor αTPMT: thiopurine S-methyltransferaseTRPV1: transient receptor potential vanilloid type 1TYK2: tyrosine kinase 2UV: ultravioletVZV: varicella-zoster virus SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/13 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=1193243504 ER -